Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham ...

On Friday, Precigen Inc (PGEN) stock saw a modest uptick, ending the day at $0.95 which represents a slight increase of $0.04 or 4.40% from the prior close of $0.91. The stock opened at $0.92 and ...

Terry Duffy is pulling all stops to thwart Howard Lutnick’s plan to launch rival contracts that clear in London.

Arcellx (NASDAQ:ACLX – Get Free Report) had its price target boosted by equities researchers at Canaccord Genuity Group from $85.00 to $115.00 in a report released on Thursday, Benzinga reports. The ...

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

The VanEck Uranium and Nuclear ETF NLR has advanced 15.7% so far in October, on track to score it best month since April 2009. The Global X Uranium ETF URA is up around 17% in the same period, with ...

Cantor Fitzgerald analyst initiates coverage on PureCycle Technologies, with an Overweight rating and a price forecast of $14 ...

Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Arcellx Inc (ACLX – Research Report) today and set a price target of ...

Oct. 17, 2024 — A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile ...